BioCentury
ARTICLE | Clinical News

Vimpat lacosamide: Phase III data

October 19, 2015 7:00 AM UTC

Top-line data from a double-blind, international Phase III trial in 888 newly or recently diagnosed adult patients with partial-onset seizures showed that lacosamide met the primary endpoint of non-in...